Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders

Last updated: August 19, 2024
Sponsor: Centre Hospitalier Henri Laborit
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mood Disorders

Psychosis

Schizotypal Personality Disorder (Spd)

Treatment

ESSME questionnaire

Clinical Study ID

NCT05349513
2022-A00080-43
  • Ages 18-65
  • All Genders

Study Summary

The study use a new ecological questionnaire called ESSME developed by a care team in order to evaluate ecological environment of patients with schizophrenia-like disorders.

Indeed, evaluation in an ecological environment would make it possible to be as close as possible to the concerns of theses patients, which could improve the care of this population, by making it possible to set with the patient objectives anchored in their daily life.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • man or woman aged 18 to 65 inclusive;

  • diagnosis of schizophrenia or schizoaffective disorder according to the Diagnosticand Statistical Manual of Mental Disorders version number 5 (DSM-V) criteria;

  • patient receiving care in a Center for Rehabilitation and Intersectoral TherapeuticActivities (CREATIV);

  • person who consented to the study;

  • affiliate or beneficiary of a social security scheme.

Exclusion

Exclusion Criteria:

  • patient aged under 18 or over 65;

  • pregnant or breastfeeding women;

  • person unable or unwilling to receive a home visit;

  • person not consenting to the study;

  • presence of a diagnosis of an associated neurodevelopmental disorder;

  • presence of a diagnosis of dementia or associated neurodegenerative process;

  • person with a level of French language insufficient to understand the items.

Study Design

Total Participants: 56
Treatment Group(s): 1
Primary Treatment: ESSME questionnaire
Phase:
Study Start date:
February 23, 2022
Estimated Completion Date:
February 28, 2026

Study Description

The duration of patient's participation to the study is 6 months plus 7 to 14 days.

The study includes the following visits :

  • V0: Inclusion visit (Day 0) with the administration of standard of care questionnaires;

  • V1: visit at patient's home (Day 0 +7 to 14 days) with the administration of the experimental ESSME questionnaire;

  • V2: follow-up visit at 6 months (M6) with the administration of the same standard of care questionnaires than at the inclusion visit;

  • V3: visit at patient's home (M6 + 7 to 14 days) with the administration of the experimental ESSME questionnaire.

Connect with a study center

  • Centre Hospitalier Henri Laborit

    Poitiers, 86000
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.